General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2020-08-07 | 2020-06 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-05-06 | POLAR ASSET MANAGEMENT PARTNERS INC. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-03-30 | Alpine Global Management, LLC | 622.39K | 7.66M | 1.75% |
2021-03-30 | Marshall Wace North America L.P. | 527.58K | 6.49M | 1.49% |
2021-06-29 | FNY Investment Advisers, LLC | 406.88K | 5.55M | 1.15% |
2021-03-30 | Citadel Advisors LLC | 403.12K | 4.96M | 1.14% |
2021-03-30 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 396.68K | 4.88M | 1.12% |
2021-03-30 | Owl Creek Asset Management, L.P. | 273.19K | 3.36M | 0.77% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-06-29 | Mairs & Power Small Cap Fund | 69.00K | 940.47K | 0.19% |
2021-06-29 | ETF Series Solutions-Defiance Next Gen SPAC Derived ETF | 9.42K | 128.45K | 0.03% |
What haapen
Hint: Need Vaccine every year for whole world like flu shot.! Why? See bellow:
1: To save the people
2: To save Jobs
3: To save the business
4: To Save the Companies
5: To Save the cities
6: To save the Countries
7: To save the Continent
8: To save the World
9: To save the Economy
10: Save the planet
Note: if you would need painkiller with would you take same frequency as you are taking ??????
I would love $VXRT
Important note: Sorry who sold this morning and pre market.
$THCB
Microvast
2000 followers on Twitter
Just another crap spac
In my opinion All cryptos will hit 50% + EOY. (Invest with your own risk/reward and DD).Get 10% bonus at following link in Binance . Their savings rate for USDT , BNB in more that 6.30%, bank rate is 0.05% !!!!!! Hahaha
https://accounts.binance.com/en/register?ref=NPF0TKH6
https://investorplace.com/2021/02/thcb-stock-why-workhorses-stumble-helps-the-microvast-spac-merger/
“To start, investors should be familiar with the big news moving THCB stock. Essentially, the United States Postal Service has been promising to electrify its mail carrier fleet for several years. Workhorse was considered a frontrunner in the contract war, but ultimately lost out to Oshkosh. This contract brings with it $482 million and a chance to design and produce the newest mail carrier. It also comes with as much as $5.7 billion in revenue.”
“For right now, that means THCB stock should be on your radar. Although shares are dipping on Wednesday, it is very likely a temporary move. Do your own research, and know the Oshkosh-Microvast relationship is quite appealing.”
Break 23 abs watch the fun
Soon QS type of run expected
Can you even imagine how many vehicles will be USPS getting all across the US and THCB will be the battery provider??? Hold that thought and your stocks
$THCB just look at $RMO
This stock is heading back to 15, then 12
It is the same ol story line of these spacs.
Many will be gone in a few years
Relax, turn on a movie. Let nature takes it course. Up or down. Come back in 30 days. Almost every car makers is focusing on EV. Is it green where you are standing yet?
What a great idea sold all THCB at the high and put it into RMO at the low
Glad I sold at the close. Didn’t get to greedy will get back in cheaper.
This is gonna do like Qs when people wake up
Party all week
Dynavax price target raised to $15 from $14 at H.C. Wainwright H.C. Wainwright analyst Edward White raised the firm's price target on Dynavax Technologies to $15 from $14 and reiterates a Buy rating on the shares. Dynavax and Clover Biopharmaceuticals this morning announced plans to initiate a global Phase 2/3 efficacy trial with Clover's S-trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum. CpG 1018 is the adjuvant used in Heplisav-B, Dynavax's marketed vaccine, White tells investors in a research note. The analyst reminds investors that Dynavax currently has five collaborations in place that are focused on developing COVID-19 vaccines. He estimates CpG 1018 adjuvant sales for COVID-19 vaccines of $100M in 2021
Read more at:
https://thefly.com/n.php?id=3238123
Transferring money from the impatient to the patient